BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 28730537)

  • 1. Lung cancer as a paradigm for precision oncology in solid tumours.
    Schallenberg S; Merkelbach-Bruse S; Buettner R
    Virchows Arch; 2017 Aug; 471(2):221-233. PubMed ID: 28730537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective on Precision Medicine in Oncology.
    Johnson TM
    Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised cancer medicine.
    Jackson SE; Chester JD
    Int J Cancer; 2015 Jul; 137(2):262-6. PubMed ID: 24789362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision medicine in pediatric oncology.
    Forrest SJ; Geoerger B; Janeway KA
    Curr Opin Pediatr; 2018 Feb; 30(1):17-24. PubMed ID: 29189430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized therapy for lung cancer.
    Moreira AL; Eng J
    Chest; 2014 Dec; 146(6):1649-1657. PubMed ID: 25451351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Master Protocol Concept.
    Redman MW; Allegra CJ
    Semin Oncol; 2015 Oct; 42(5):724-30. PubMed ID: 26433553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Personalized therapy of lung cancer - current standard and future challenges].
    Riedel R; Wolf J
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1660-1668. PubMed ID: 29078211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Challenges in Cancer Treatment.
    Zugazagoitia J; Guedes C; Ponce S; Ferrer I; Molina-Pinelo S; Paz-Ares L
    Clin Ther; 2016 Jul; 38(7):1551-66. PubMed ID: 27158009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.
    Fang J; Cai C; Wang Q; Lin P; Zhao Z; Cheng F
    CPT Pharmacometrics Syst Pharmacol; 2017 Mar; 6(3):177-187. PubMed ID: 28294568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical testing for molecular targets for personalized treatment in lung cancer.
    Lam DC
    Respirology; 2013 Feb; 18(2):233-7. PubMed ID: 22957484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successes and limitations of targeted cancer therapy in lung cancer.
    Suda K; Mitsudomi T
    Prog Tumor Res; 2014; 41():62-77. PubMed ID: 24727987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules, big impact: 20 years of targeted therapy in oncology.
    Bedard PL; Hyman DM; Davids MS; Siu LL
    Lancet; 2020 Mar; 395(10229):1078-1088. PubMed ID: 32222192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Targeted Therapies Are Changing Treatment for Non-Small Cell Lung Cancer.
    Becze E
    ONS Connect; 2016 Feb; 31(2):24-5. PubMed ID: 26930998
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beating cancer with synthetic genes: towards more effective treatments through autonomous genetic programs].
    Morel M
    Med Sci (Paris); 2017; 33(6-7):591-593. PubMed ID: 28990556
    [No Abstract]   [Full Text] [Related]  

  • 19. Precision Medicine in Lung Cancer Treatment.
    Shah DR; Masters GA
    Surg Oncol Clin N Am; 2020 Jan; 29(1):15-21. PubMed ID: 31757310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.